Revenue by segment
Revenue by segment – (Table representation)
Earnings release date | UnitedHealthcare | Optum Health | Optum Insight | Optum Rx | Eliminations | Total |
|---|---|---|---|---|---|---|
Earnings release date:21 Apr. 26 | UnitedHealthcare: 86,265,000,000 $ | Optum Health: 24,109,000,000 $ | Optum Insight: 5,125,000,000 $ | Optum Rx: 35,736,000,000 $ | Eliminations: -39,514,000,000 $ | Total: 111,721,000,000 $ |
Earnings release date:27 Jan. 26 | UnitedHealthcare: 87,113,000,000 $ | Optum Health: 25,543,000,000 $ | Optum Insight: 5,044,000,000 $ | Optum Rx: 41,456,000,000 $ | Eliminations: -45,941,000,000 $ | Total: 113,215,000,000 $ |
Earnings release date:28 Oct. 25 | UnitedHealthcare: 87,070,000,000 $ | Optum Health: 25,900,000,000 $ | Optum Insight: 4,915,000,000 $ | Optum Rx: 39,679,000,000 $ | Eliminations: -44,403,000,000 $ | Total: 113,161,000,000 $ |
Earnings release date:29 Jul. 25 | UnitedHealthcare: 86,103,000,000 $ | Optum Health: 25,205,000,000 $ | Optum Insight: 4,828,000,000 $ | Optum Rx: 38,459,000,000 $ | Eliminations: -42,979,000,000 $ | Total: 111,616,000,000 $ |
Earnings release date:17 Apr. 25 | UnitedHealthcare: 84,617,000,000 $ | Optum Health: 25,309,000,000 $ | Optum Insight: 4,630,000,000 $ | Optum Rx: 35,132,000,000 $ | Eliminations: -40,113,000,000 $ | Total: 109,575,000,000 $ |
Earnings release date:16 Jan. 25 | UnitedHealthcare: 74,132,000,000 $ | Optum Health: 25,660,000,000 $ | Optum Insight: 4,781,000,000 $ | Optum Rx: 35,774,000,000 $ | Eliminations: -39,540,000,000 $ | Total: 100,807,000,000 $ |
Earnings release date:15 Oct. 24 | UnitedHealthcare: 74,853,000,000 $ | Optum Health: 25,917,000,000 $ | Optum Insight: 4,931,000,000 $ | Optum Rx: 34,207,000,000 $ | Eliminations: -39,088,000,000 $ | Total: 100,820,000,000 $ |
Earnings release date:16 Jul. 24 | UnitedHealthcare: 73,866,000,000 $ | Optum Health: 27,050,000,000 $ | Optum Insight: 4,543,000,000 $ | Optum Rx: 32,415,000,000 $ | Eliminations: -39,019,000,000 $ | Total: 98,855,000,000 $ |
Earnings release date:16 Apr. 24 | UnitedHealthcare: 75,357,000,000 $ | Optum Health: 26,731,000,000 $ | Optum Insight: 4,502,000,000 $ | Optum Rx: 30,835,000,000 $ | Eliminations: -37,629,000,000 $ | Total: 99,796,000,000 $ |
Earnings release date:12 Jan. 24 | UnitedHealthcare: 70,808,000,000 $ | Optum Health: 24,534,000,000 $ | Optum Insight: 4,785,000,000 $ | Optum Rx: 31,166,000,000 $ | Eliminations: -36,866,000,000 $ | Total: 94,427,000,000 $ |
Earnings release date:13 Oct. 23 | UnitedHealthcare: 69,853,000,000 $ | Optum Health: 23,864,000,000 $ | Optum Insight: 4,977,000,000 $ | Optum Rx: 28,857,000,000 $ | Eliminations: -35,190,000,000 $ | Total: 92,361,000,000 $ |
Earnings release date:14 Jul. 23 | UnitedHealthcare: 70,231,000,000 $ | Optum Health: 23,917,000,000 $ | Optum Insight: 4,674,000,000 $ | Optum Rx: 28,646,000,000 $ | Eliminations: -34,565,000,000 $ | Total: 92,903,000,000 $ |
Earnings release date:14 Apr. 23 | UnitedHealthcare: 70,468,000,000 $ | Optum Health: 23,004,000,000 $ | Optum Insight: 4,496,000,000 $ | Optum Rx: 27,418,000,000 $ | Eliminations: -33,455,000,000 $ | Total: 91,931,000,000 $ |
Earnings release date:13 Jan. 23 | UnitedHealthcare: 63,046,000,000 $ | Optum Health: 18,446,000,000 $ | Optum Insight: 4,387,000,000 $ | Optum Rx: 25,854,000,000 $ | Eliminations: -28,946,000,000 $ | Total: 82,787,000,000 $ |
Earnings release date:14 Oct. 22 | UnitedHealthcare: 61,995,000,000 $ | Optum Health: 18,463,000,000 $ | Optum Insight: 3,693,000,000 $ | Optum Rx: 25,203,000,000 $ | Eliminations: -28,460,000,000 $ | Total: 80,894,000,000 $ |
Earnings release date:15 Jul. 22 | UnitedHealthcare: 62,105,000,000 $ | Optum Health: 17,583,000,000 $ | Optum Insight: 3,282,000,000 $ | Optum Rx: 24,805,000,000 $ | Eliminations: -27,443,000,000 $ | Total: 80,332,000,000 $ |
Expand table
Expenses
Expenses – (Table representation)
Earnings release date | Medical costs | Operating costs | Cost of products sold | Depreciation and amortization | Total |
|---|---|---|---|---|---|
Earnings release date:21 Apr. 26 | Medical costs: 73,489,000,000 $ | Operating costs: 15,390,000,000 $ | Cost of products sold: 12,823,000,000 $ | Depreciation and amortization: 1,029,000,000 $ | Total: 102,731,000,000 $ |
Earnings release date:27 Jan. 26 | Medical costs: 82,041,000,000 $ | Operating costs: 16,997,000,000 $ | Cost of products sold: 12,680,000,000 $ | Depreciation and amortization: 1,117,000,000 $ | Total: 112,835,000,000 $ |
Earnings release date:28 Oct. 25 | Medical costs: 79,958,000,000 $ | Operating costs: 15,223,000,000 $ | Cost of products sold: 12,566,000,000 $ | Depreciation and amortization: 1,099,000,000 $ | Total: 108,846,000,000 $ |
Earnings release date:29 Jul. 25 | Medical costs: 78,585,000,000 $ | Operating costs: 13,778,000,000 $ | Cost of products sold: 13,019,000,000 $ | Depreciation and amortization: 1,084,000,000 $ | Total: 106,466,000,000 $ |
Earnings release date:17 Apr. 25 | Medical costs: 73,411,000,000 $ | Operating costs: 13,594,000,000 $ | Cost of products sold: 12,390,000,000 $ | Depreciation and amortization: 1,061,000,000 $ | Total: 100,456,000,000 $ |
Earnings release date:16 Jan. 25 | Medical costs: 67,035,000,000 $ | Operating costs: 12,494,000,000 $ | Cost of products sold: 12,464,000,000 $ | Depreciation and amortization: 1,041,000,000 $ | Total: 93,034,000,000 $ |
Earnings release date:15 Oct. 24 | Medical costs: 65,957,000,000 $ | Operating costs: 13,280,000,000 $ | Cost of products sold: 11,834,000,000 $ | Depreciation and amortization: 1,041,000,000 $ | Total: 92,112,000,000 $ |
Earnings release date:16 Jul. 24 | Medical costs: 65,458,000,000 $ | Operating costs: 13,162,000,000 $ | Cost of products sold: 11,340,000,000 $ | Depreciation and amortization: 1,020,000,000 $ | Total: 90,980,000,000 $ |
Earnings release date:16 Apr. 24 | Medical costs: 65,735,000,000 $ | Operating costs: 14,077,000,000 $ | Cost of products sold: 11,056,000,000 $ | Depreciation and amortization: 997,000,000 $ | Total: 91,865,000,000 $ |
Earnings release date:12 Jan. 24 | Medical costs: 62,231,000,000 $ | Operating costs: 13,339,000,000 $ | Cost of products sold: 10,194,000,000 $ | Depreciation and amortization: 974,000,000 $ | Total: 86,738,000,000 $ |
Earnings release date:13 Oct. 23 | Medical costs: 59,550,000,000 $ | Operating costs: 13,855,000,000 $ | Cost of products sold: 9,423,000,000 $ | Depreciation and amortization: 1,007,000,000 $ | Total: 83,835,000,000 $ |
Earnings release date:14 Jul. 23 | Medical costs: 60,268,000,000 $ | Operating costs: 13,809,000,000 $ | Cost of products sold: 9,748,000,000 $ | Depreciation and amortization: 1,021,000,000 $ | Total: 84,846,000,000 $ |
Earnings release date:14 Apr. 23 | Medical costs: 59,845,000,000 $ | Operating costs: 13,625,000,000 $ | Cost of products sold: 9,405,000,000 $ | Depreciation and amortization: 970,000,000 $ | Total: 83,845,000,000 $ |
Earnings release date:13 Jan. 23 | Medical costs: 53,591,000,000 $ | Operating costs: 13,009,000,000 $ | Cost of products sold: 8,314,000,000 $ | Depreciation and amortization: 982,000,000 $ | Total: 75,896,000,000 $ |
Earnings release date:14 Oct. 22 | Medical costs: 52,635,000,000 $ | Operating costs: 11,663,000,000 $ | Cost of products sold: 8,306,000,000 $ | Depreciation and amortization: 828,000,000 $ | Total: 73,432,000,000 $ |
Earnings release date:15 Jul. 22 | Medical costs: 52,093,000,000 $ | Operating costs: 11,709,000,000 $ | Cost of products sold: 8,596,000,000 $ | Depreciation and amortization: 802,000,000 $ | Total: 73,200,000,000 $ |
Expand table
Profitability
Profitability – (Table representation)
Earnings release date | Net income (shareholders) |
|---|---|
Earnings release date:21 Apr. 26 | Net income (shareholders): 6,280,000,000 $ |
Earnings release date:27 Jan. 26 | Net income (shareholders): 10,000,000 $ |
Earnings release date:28 Oct. 25 | Net income (shareholders): 2,348,000,000 $ |
Earnings release date:29 Jul. 25 | Net income (shareholders): 3,406,000,000 $ |
Earnings release date:17 Apr. 25 | Net income (shareholders): 6,292,000,000 $ |
Earnings release date:16 Jan. 25 | Net income (shareholders): 5,543,000,000 $ |
Earnings release date:15 Oct. 24 | Net income (shareholders): 6,055,000,000 $ |
Earnings release date:16 Jul. 24 | Net income (shareholders): 4,216,000,000 $ |
Earnings release date:16 Apr. 24 | Net income (shareholders): -1,409,000,000 $ |
Earnings release date:12 Jan. 24 | Net income (shareholders): 5,455,000,000 $ |
Earnings release date:13 Oct. 23 | Net income (shareholders): 5,841,000,000 $ |
Earnings release date:14 Jul. 23 | Net income (shareholders): 5,474,000,000 $ |
Earnings release date:14 Apr. 23 | Net income (shareholders): 5,611,000,000 $ |
Earnings release date:13 Jan. 23 | Net income (shareholders): 4,761,000,000 $ |
Earnings release date:14 Oct. 22 | Net income (shareholders): 5,262,000,000 $ |
Earnings release date:15 Jul. 22 | Net income (shareholders): 5,070,000,000 $ |
Expand table
Profit margin (shareholders) in %
Profit margin (shareholders) in % – (Table representation)
Earnings release date | Profit Margin (shareholders) |
|---|---|
Earnings release date:21 Apr. 26 | Profit Margin (shareholders): 5.62 % |
Earnings release date:27 Jan. 26 | Profit Margin (shareholders): 0.01 % |
Earnings release date:28 Oct. 25 | Profit Margin (shareholders): 2.07 % |
Earnings release date:29 Jul. 25 | Profit Margin (shareholders): 3.05 % |
Earnings release date:17 Apr. 25 | Profit Margin (shareholders): 5.74 % |
Earnings release date:16 Jan. 25 | Profit Margin (shareholders): 5.5 % |
Earnings release date:15 Oct. 24 | Profit Margin (shareholders): 6.01 % |
Earnings release date:16 Jul. 24 | Profit Margin (shareholders): 4.26 % |
Earnings release date:16 Apr. 24 | Profit Margin (shareholders): -1.41 % |
Earnings release date:12 Jan. 24 | Profit Margin (shareholders): 5.78 % |
Earnings release date:13 Oct. 23 | Profit Margin (shareholders): 6.32 % |
Earnings release date:14 Jul. 23 | Profit Margin (shareholders): 5.89 % |
Earnings release date:14 Apr. 23 | Profit Margin (shareholders): 6.1 % |
Earnings release date:13 Jan. 23 | Profit Margin (shareholders): 5.75 % |
Earnings release date:14 Oct. 22 | Profit Margin (shareholders): 6.5 % |
Earnings release date:15 Jul. 22 | Profit Margin (shareholders): 6.31 % |
Expand table